Injective breaks down walls between Ethereum and Cosmos with its EVM

Injective has just deployed its native EVM mainnet, marking a turning point in the evolution of layer 1 blockchains. This integration allows Ethereum developers to leverage the power of Cosmos without sacrificing performance. But will this technical feat be enough to reverse the downward trend of the INJ token, down more than 60%?

Injective deploys native EVM support on Cosmos

Injective took a major step forward in its roadmap on Tuesday with the activation of its EVM mainnet.

Specifically, the blockchain inherited from Binance now allows developers to deploy Ethereum applications directly on its Cosmos infrastructure without any code adaptation. This technical feat creates a bridge between two previously isolated worlds.

The innovation lies in the “MultiVM” environment that Injective has been methodically building since 2023. After months of testing on its layer 2 inEVM, the team succeeded in its bet: making WebAssembly and EVM coexist on the same platform.

Developers can now choose their preferred virtual machine, with Solana’s expected soon, while sharing liquidity, resources, and modules.

This unified architecture eliminates usual frictions. “No more manual interventions between user environments“, explains the Injective team. 

The MultiVM Token Standard guarantees a consistent representation of assets throughout the ecosystem, removing duplicate token versions that cause confusion. Transactions become atomic: they execute fully or are canceled, thus protecting user funds.

Performance demonstrates the system’s efficiency. With block times of 0.64 seconds and fees dropping to $0.00008, Injective positions itself as a serious alternative for decentralized applications hungry for transactions. This speed, combined with Ethereum compatibility, could attract developers tired of other networks’ prohibitive fees.

Institutional appeal confirms itself

The activation of the EVM comes in a favorable context for Injective. Indeed, in October, 21Shares filed a spot ETF application with the SEC, joining Canary Capital in this effort.

The network has multiplied strategic partnerships with Google Cloud, T-Mobile, and Deutsche Telekom, consolidating its credibility. 

Its capacity to handle more than 25,000 transactions per second via a DPoS consensus mechanism attracts professional players’ attention. The preexisting infrastructure for pre-IPO markets and the creation of the Injective Council strengthen this institutional dimension.

The INJ token price, although far from its $52.75 peak in March 2024, remains around $8.75. This relative stability, despite crypto volatility, reflects underlying investor confidence. 

Potential ETF approval could catalyze a new dynamic, offering institutional investors regulated exposure to the layer 1 DeFi ecosystem.

In short, native EVM integration positions Injective at the crossroads between technical innovation and mainstream adoption. By unifying several virtual machines while preserving exceptional performance, the blockchain is shaping an environment where Ethereum, Cosmos, and soon Solana developers can collaborate without compromise.